Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2017 June;29(2) > Minerva Biotecnologica 2017 June;29(2):89-100

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA BIOTECNOLOGICA

Rivista di Biologia Molecolare e Biotecnologie


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,25


eTOC

 

REVIEW  FREEfree


Minerva Biotecnologica 2017 June;29(2):89-100

DOI: 10.23736/S1120-4826.16.02172-8

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Camelid variable fragments of heavy chain antibodies (Nanobody): its applications in research, diagnosis and therapy

Hossein AGHAMOLLAEI 1, Seyed L. MOUSAVI GARGARI 2, Mohamad J. RASAEE 3, Mostafa GHANEI 4

1 Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran; 2 Department of Biology, Faculty of Basic Science, Shahed University, Tehran, Iran; 3 Medical Biotechnology Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran; 4 Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran


PDF  


Camelids produce functional antibodies lacking light chains with their single N-terminal domains capable of binding to antigen. The antigen-binding site of these unusual heavy chain antibodies can be easily generated as recombinant proteins in variety of hosts as single domain antibodies (sdAbs) or nanobodies. The strict monomeric behavior and small size in combination with other biochemical properties including high specificity, affinity and high solubility, make single domain antibodiesas as ideal tools which can be used in different areas. In this review we overview different properties of nanobodies, their production process and their application in biotechnology, imaging, detection, infection treatment, and cancer therapy.


KEY WORDS: Biotechnology - Neoplasms - Diagnosis - Infection - Therapy

inizio pagina

Publication History

Issue published online: January 24, 2017
Manuscript accepted: September 21, 2016
Manuscript received: September 13, 2016

Per citare questo articolo

Aghamollaei H, Mousavi Gargari SL, Rasaee MJ, Ghanei M. Camelid variable fragments of heavy chain antibodies (Nanobody): its applications in research, diagnosis and therapy. Minerva Biotec 2017;29:89-100. DOI: 10.23736/S1120-4826.16.02172-8

Corresponding author e-mail

mlatifm@yahoo.com